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Abstract
Background: The identification of independent clinical risk 
factors for necrotizing enterocolitis (NEC) may contribute to 
early selection of infants at risk, allowing for the develop-
ment of targeted strategies aimed at the prevention of NEC. 
Objective: The objective of this study was to identify inde-
pendent risk factors contributing to the development of NEC 
in a large multicenter cohort. Methods: This prospective co-
hort study was performed in 9 neonatal intensive care units. 
Infants born at a gestational age ≤30 weeks were included. 
Demographic and clinical data were collected daily until day 
28 postnatally. Factors predictive of the development of NEC 
were identified using univariate and multivariable analyses 
in a 1: 5 matched case-control cohort. Results: In total, 843 
infants (56 NEC cases) were included in this study. In the 
case-control cohort, univariate analysis identified sepsis pri-
or to the onset of NEC and formula feeding to be associated 
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with an increased risk of developing NEC, whereas the ad-
ministration of antibiotics directly postpartum was inversely 
associated with NEC. In a multivariable logistic regression 
model, enteral feeding type and the number of days paren-
terally fed remained statistically significantly associated with 
NEC, whereas the administration of antibiotics directly after 
birth was associated with a lower risk of developing NEC. 
Conclusions: Formula feeding and prolonged (duration of) 
parenteral feeding were associated with an increased risk of 
NEC. Contrary to expectations, the initiation of treatment 
with antibiotics within 24 h after birth was inversely associ-
ated with NEC. © 2018 The Author(s)
Published by S. Karger AG, Basel
Introduction
Necrotizing enterocolitis (NEC) is the most common 
severe gastrointestinal disease in infants born preterm. A 
new guideline on perinatal treatment of infants born ex-
tremely preterm was implemented in the Netherlands in 
2010, lowering the border of viability to support active 
treatment from 25 to 24 weeks’ gestation. This resulted in 
an increase in NEC incidences (16% in infants born at a 
gestational age [GA] < 28 weeks) and associated mortality 
[1].
The etiology of NEC is considered multifactorial, but 
the contribution of individual risk factors remains yet 
to be elucidated [2]. Several studies, mostly retrospec-
tive in design, have aimed to identify independent risk 
factors for NEC. Prematurity and low birth weight were 
the most consistently identified risk factors for the de-
velopment of NEC [3]. Other reported risk factors in-
clude the administration of bovine-origin formula [4], 
low Apgar scores [5], small for GA [6], treatment of 
patent ductus arteriosus (PDA) [7], erythrocyte trans-
fusions [8], and nosocomial infections [9]. Studies on 
potential effects of postnatal antibiotics on NEC inci-
dence have shown conflicting results [10]. The identifi-
cation of clinical factors contributing to the develop-
ment of NEC may allow for the selection of neonates at 
risk for NEC and could contribute to the development 
of strategies aimed at the prevention and early treat-
ment of NEC. Therefore, the aim of this study was to 
identify independent variables that are associated with 
the development of NEC. The daily collection of a wide 
variety of clinical variables, including exposure to anti-




This prospective cohort study, including infants born at a GA 
≤30 weeks, was conducted between October 2014 and January 2017 
at 2 level III and 7 level IV neonatal intensive care units (NICUs) in 
the Netherlands and Belgium (online suppl. Table 1; for all online 
suppl. material, see www.karger.com/doi/10.1159/000489677). In 
that study, potential diagnostic biomarkers for NEC and sepsis are 
investigated [11, 12]. None of the participating NICUs administered 
probiotics routinely. This study was approved by the local Institu-
tional Review Boards of all 9 medical centers (2014.386 amendment 
A2016.363). Informed consent was obtained from all parents.
Data on GA, birth weight, gender, delivery mode, multi- 
ple births, preterm premature rupture of membranes (PPROM) 
(≥24 h before delivery), and Apgar scores were collected. Addi-
tional clinical data, including treatment of a significant PDA, di-
agnosis of NEC or sepsis, including causative organism, adminis-
tration of antibiotics, transfusions with erythrocytes, use of central 
catheter, and parenteral and enteral feeding practices were pro-
spectively collected. Data collection was ceased in case of transfer 
to another hospital. Infants were excluded in case of a missing or 
incomplete medical file.
Definitions
NEC cases were defined as infants diagnosed with NEC stage 
≥IIA (Bell’s classification). NEC cases were independently re-
viewed by two experts (T.G.J.d.M. and H.J.N.), and consensus was 
met in all cases. Infants meeting all 3 Vermont Oxford criteria for 
sepsis were identified as sepsis cases, including (1) clinical symp-
toms of generalized infection (e.g., temperature instability, apnea, 
hemodynamic instability); (2) isolation of a pathogen from a blood 
culture; and (3) treatment with antibiotics for ≥5 days directed to 
this pathogen [13]. A hemodynamically significant PDA was de-
fined as an echocardiographic confirmed PDA for which pharma-
cological (ibuprofen, indomethacin) or surgical treatment was ini-
tiated. 
Exposure to antibiotics was defined in two ways. The first def-
inition, describing the duration of administrating antibiotics initi-
ated within 24 h after birth, was categorized into (1) 0 days, (2) ≤3 
days, or (3) > 3 days. In addition, types of antibiotics were also 
noted. The second definition described the cumulative number of 
days a patient was on any treatment with antibiotics. Exposure to 
central lines and red blood cell transfusion were noted as cumula-
tive number of days any central line was present or erythrocytes 
were administered, respectively.
For enteral feeding types, we defined the following subgroups: 
(1) breast milk fed, defined as the average daily enteral feeding vol-
ume consisting of ≥80% breast milk, including donor milk; (2) 
formula fed, defined as the average daily enteral feeding volume 
consisting of ≥50% formula; and (3) a combination of both for-
mula and breast milk, including infants not meeting the criteria of 
the first two subgroups. Full enteral feeding was defined when for 
at least two consecutive days no additional parenteral feeding 
(amino acids or lipids) was administered. Exposure to parenteral 
feeding was noted as the cumulative number of days any nutri-
tional solution (lipids or amino acids) was administered parenter-
ally. Increments in feeding volumes during the first 7 days postna-
tally were defined as the daily increase in enteral feeding volume 
relative to the birth weight (mL/kg/day).





We performed two statistical analyses on the cohort. First, dur-
ing the entire inclusion period of 28 days, demographic and clini-
cal variables from all infants with NEC were compared with the 
variables from all infants without NEC. Second, each NEC case was 
matched to 5 controls, defined as infants without NEC. The match-
ing procedure was based on GA (maximum difference of 3 days), 
birth weight (maximum difference of 400 g), and postnatal age 
(total number of hospital days prior to NEC in matched cases). In 
this nested case-control cohort, variables of interest were collected 
for both the cases and matched controls from birth up to postnatal 
age of NEC diagnosis (t0). For example, if a case developed NEC 
on postnatal day 12, data was collected from both the case and 
matched controls from birth up to the postnatal age of 12 days. 
Statistical analysis was performed with Statistical Package for 
the Social Science (SPSS) version 22.0. Predictive factors were 
identified by univariate analysis and corresponding p values, odds 
ratios and 95% confidence intervals were noted. Variables with a 
two-sided p value ≤0.20 were included in the multivariable logistic 
regression model. This model was constructed using the forward 
stepwise selection method, ultimately including statistically sig-
nificant variables, defined as having a p value < 0.05. Since center-
specific incidence rates were relatively low, birth center was ex-
cluded from the regression models. 
Results
Total Cohort
In total, 843 preterm infants were included during the 
study period. Fourteen (1.7%) were excluded based on 
missing or incomplete medical files. Of the 829 remaining 
infants, 56 (6.8%) developed NEC within the first 28 post-
natal days. NEC was diagnosed at a median postnatal age 
of 12 days [IQR: 8.3–18 days]. The distribution of sever-
ity was stage IIA in 19 (33.9%) cases, IIB in 16 (28.6%) 
cases, IIIA in 8 (14.3%) cases, and IIIB in 13 (23.2%). Ta-
ble 1 depicts incidence rates per center (displayed encod-
ed). An overview of the demographic and clinical charac-
teristics of the cases versus controls during the entire in-
clusion period of 28 days is depicted in Table 2. In the 
NEC population, 21.4% of the infants died during the 
follow-up period, compared to 4.8% of the controls. 
Case-Control Cohort
Overall, 56 cases and 280 matched controls were in-
cluded in the case-control analysis. Outcomes of the uni-







Median age at the development of 
NEC, days [IQR]
1 14 52 (6.2) 2 (3.8) 8.5
2 28 179 (21.2) 8 (4.5) 14.5 [6.5–19.8]
3 11 104 (12.3) 5 (4.8) 15 [9–23.5]
4 17 90 (10.7) 5 (5.6) 16 [13.5–22.5]
5 4 17 (2.0) 1 (5.9) 10
6 27 114 (13.5) 8 (7.0) 14 [7.5–22.3]
7 28 165 (19.6) 14 (8.5) 9.5 [7.8–17.3]
8 27 65 (7.7) 6 (9.2) 15 [12–21.8]
9 10 57 (6.8) 7 (12.3) 9 [6–10]





























































Fig. 1. Median daily enteral feeding volume increase during the 
first 7 postnatal days. Median daily enteral feeding volume increase 
(mL/kg/day) with corresponding interquartile ranges are shown 
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variate analysis are depicted in Table 3, demonstrating 
both sepsis and formula feeding prior to clinical presenta-
tion to be associated with an increased risk of developing 
NEC, whereas initiating of the administration of antibiot-
ics within 24 h after birth was inversely associated with 
NEC. In total, 23.2% (n = 13) of the cases did not receive 
antibiotics within 24 h after birth compared to 9.6% (n = 
27) of the controls (Fig. 1a). Figure 1b depicts the types of 
antibiotics administered directly postnatally per study 
group. Daily enteral feeding increments per study group 
are depicted in Figure 2.
In the multivariable model, including all 8 variables 
with a p value ≤0.20 (online suppl. Table 2), treatment 
with antibiotics administrated directly postnatally (p = 
0.004) remained inversely associated with the develop-
ment of NEC. More specifically, empiric use of antibiotics 
for a prolonged period of time (> 3 days) was associated 
with decreased odds of developing NEC (OR 0.227 [95% 
CI 0.079–0.648]; p = 0.006), whereas the odds for infants 
receiving antibiotics for ≤3 days maximally were: OR 
0.213 [0.084–0.544]; p = 0.001. Concerning formula feed-
ing, the odds associated with the development of NEC 
increased for formula-fed infants (OR 3.36 [1.40–8.03]; 
p = 0.006) in the multivariable analysis compared to uni-
variable analysis. In addition, the number of days infants 
received parenteral feeding prior to t0 (OR 1.19 [1.07–
1.31]; p = 0.001) was also associated with an increased 
odds for developing NEC (Table 3).
Discussion
In this matched prospective multicenter cohort study, 
we aimed to identify demographic and clinical factors 
that preceded the development of NEC in preterm in-
fants. Multivariable logistic regression modeling demon-





p value Unadjusted OR
[95% CI]
Median gestational age [IQR], weeks+days 26+6 [25+2 to 27+6] 27+6 [26+3 to 29+0] <0.001 0.951 [0.929–0.974]
Mean birth weight ± SD, g 896±241 1,041±274.3 <0.001 0.998 [0.997–0.999]
Birth season (fall–winter)a, n (%) 31 (56) 409 (53) <0.723 1.10 [0.640–1.90]
Male gender, n (%) 28 (50) 408 (53) <0.687 0.895 [0.520–1.54]
Delivery mode (vaginal delivery), n (%) 29 (52) 354 (46) <0.391 1.27 [0.737–2.18]
Multiple births, n (%) 19 (34) 249 (32) <0.791 1.08 [0.609–1.92]
PPROM, n (%) 9 (16) 169 (22) <0.324 0.691 [0.332–1.44]
Median Apgar [IQR]
1 min 5 [3–8] 6 [4–7] <0.517 0.962 [0.855–1.08]
5 min 8 [7–9] 8 [7–9] <0.886 1.01 [0.859–1.19]
Sepsis, n (%) 37 (66) 208 (26) <0.001 5.29 [2.98–9.41]
PDA, n (%) 31 (55) 255 (33) <0.001 2.51 [1.45–4.35]
Central line exposure, n (%)









RBC transfusion exposure, n (%)









Antibiotic exposure, n (%)

























Achieved full enteral feedingc, n (%)
Median duration of parenteral feeding before being fully 









Median duration of parental feeding [IQR], days 20 [9–17.3] 10 [8–13] <0.001 1.24 [1.19–1.30]
Mortality, n (%)









CI, confidence interval; IQR, interquartile range; OR, odds ratio; PPROM, preterm premature rupture of membranes; SD, standard deviation. 
a October up to March are defined as fall-winter b Variables were not retrievable from the medical records of one participating center (n = 71 missing 
values). c Variables were not retrievable from the medical records of one participating center (n = 87 missing values).




strated only 2 independent variables to be associated with 
an increased risk of NEC: administration of predomi-
nantly formula feeding and the cumulative number of pa-
rental feeding days. Remarkably, administration of any 
antibiotics initiated within 24 h after birth was associated 
with a reduced risk of NEC.
NEC incidence in this cohort was 6.8%. Although this 
reflects incidence rates described in larger international 
cohorts [14], it is considerably lower than that of a previous 
study in the Netherlands [1]. This apparent discrepancy 
may at least partly be explained by the limited follow-up 
period of 28 days. In the current study, 21.4% of the infants 
who developed NEC died prior to reaching the age of 28 
days. Although this mortality rate is in line with available 
literature [15], NEC-associated mortality in this cohort 
may be higher due to the limited follow-up time of 28 days.
As expected, our study confirmed the significant role of 
low GA and birth weight as risk factors for the develop-
ment of NEC. During the 28 days of follow-up, preterm 
infants with NEC were more exposed to antibiotics, central 
lines, and transfusions with erythrocytes, and they were 
less likely to reach full enteral feeding at the end of the in-
clusion period, reflecting the high morbidity rate of NEC. 
An association between a hemodynamically signifi-
cant PDA and NEC was demonstrated in the overall co-
hort but not in the case-control analysis. Presumably, the 
strong association between GA and PDA may be the ex-
planation of this detected difference in the overall cohort, 
since the cases were born at a significantly lower GA. The 
currently observed absence of an association between 
transfusions with erythrocytes and NEC is supported by 
findings in a recent prospective observational study [16]. 













Median gestational age [IQR], weeks+days 26+6 [25+3 to 27+6] 26+6 [25+3 to 27+6] 0.936 1.00 [0.974–1.03]
Mean birth weight ± SD, g 896±241 892±314 0.904 1.00 [0.999–1.00]
Birth season (fall–winter)a, n (%) 31 (55) 143 (51) 0.558 1.19 [0.667–2.12]
Male gender, n (%) 28 (50) 139 (50) 0.961 1.01 [0.571–1.80]
Delivery mode (vaginal delivery), n (%) 29 (52) 133 (48) 0.558 1.19 [0.669–2.11]
Multiple births, n (%) 20 (36) 87 (31) 0.496 1.23 [0.675–2.25]
PPROM, n (%) 9 (16) 66 (24) 0.217 0.618 [0.288–1.33]
Median Apgar [IQR]
1 min 5 [3–8] 5 [3–7] 0.403 1.06 [0.929–1.20]
5 min 8 [7–9] 7 [6–8] 0.186 1.13 [0.943–1.35]



















































Ibuprofen last administered prior to t0













Central line exposure prior to t0, n (%) 









RBC transfusion exposure prior to t0, n (%)
Median duration of RBC transfusion [IQR], days
Time between last RBC transfusion and t0 [IQR], days

















Antibiotic exposure prior to t0, n (%)
Median antibiotic exposure [IQR], days













Postpartum antibiotics, n (%)
No antibiotics
1–3 days of antibiotics









































Mean enteral feeding volume increase during first 7 postnatal days ± SD, 
mL/kg/day 10.1±5.1 11.2±5.3 0.162 0.962 [0.911–1.02]
Achieved full enteral feeding prior to t0, n (%)








1.07 [0.983–1.17] 0.001 1.19 [1.07–0.1.31]
Mortality, n (%)









CI, confidence interval; IQR, interquartile range; OR, odds ratio; PPROM, preterm premature rupture of membranes; RBC, red blood cell; SD, standard deviation; t0, day of NEC onset.
a October up to March are defined as fall–winter.
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The initiation of antibiotics within 24 h after birth was 
inversely associated with the development of NEC. In 
contrast, Cotton et al. [17] demonstrated an increased 
risk of developing NEC with increasing treatment days. 
However, and in contrast to the current study, infants not 
exposed to antibiotics within 72 h postnatally were ex-
cluded. Our results are in line with the results of an ob-
servational single-center study describing a reversed as-
sociation between early initiation of treatment with anti-
biotics (within 48 h after birth) and development of NEC 
[18]. In addition, a recent randomized controlled trial on 
preterm piglets demonstrated sustained administration 
of antibiotics initiated directly after birth to be protective 
against NEC [19]. Moreover, in a recent study by Heida 
et al. [20], a NEC-associated gut microbiota composition 
was already observed to be present in the meconium. 
These observations, in combination with the absence of 
any association between the development of NEC and the 
total number of days treated with antibiotics suggest that, 
in particular, initial intestinal colonization plays an es-
sential role in the pathogenesis of NEC. Based on these 
findings, it could be hypothesized that microbial manipu-
lation, for example through the administration of target-
ed probiotics or antibiotics, may serve as an effective pre-
ventive strategy against NEC. Yet, the observational char-
acter of this study hampered the ability to explore any 
causal relationship between early colonization and the 
development of NEC. To prove any causality, future stud-
ies should focus on obstetrical and perinatal factors linked 
to longitudinal microbiota analysis. 
In addition to these microbial factors, other potential-
ly contributing factors need to be acknowledged. For ex-
ample, it is tempting to speculate that pre-eclampsia or 
intra-uterine growth restriction might have caused sub-
optimal antenatal Doppler ultrasound features which in 
turn may have led to the decision to perform an emer-
gency caesarean section. In these specific cases, adminis-
tration of antibiotics is often not initiated since an intra-
uterine infection is not suspected. Therefore, merely the 
fetal Doppler ultrasound abnormalities [21] and not the 
absence of administration of antibiotics within 24 h after 
birth may have contributed to the increased association 
with the development of NEC.
In contrast to the univariate analysis, endurance of a 
septic episode in the entire period prior to NEC was not 











































































































Fig. 2. Administration of antibiotics initiated within 24 h after birth in the matched case-control cohort. a Dif-
ference in number of consecutive days of treatment with any antibiotic. b Difference in types of administered 
antibiotics during the consecutive number of treatment days.




the multivariable analysis. Interestingly, infants develop-
ing NEC had increased odds of developing sepsis within 
24 h adjacent to clinical NEC diagnosis. Presumably, the 
release of pro-inflammatory cytokines and endotoxemia 
during NEC onset causes failure of the mucosal barrier 
function, ultimately leading to bacterial translocation and 
concurrent bloodstream infection [22]. 
In the literature, the concept of slow advancements in 
enteral feeding volumes and consequently an increased 
number of parenteral nutrition days demonstrated no 
significant alterations in the overall incidence of NEC ex-
cept in infants with a birth weight < 750 g [23]. In contrast 
to the number of parenteral feeding days, the velocity of 
enteral feeding volume expansion during the first postna-
tal week was not associated with the development of NEC. 
Although enteral feeding advancements in the first week 
did not differ between the 2 groups, we hypothesize that 
enteral feeding intolerance present after the first postna-
tal week is more prevalent in infants developing NEC, 
explaining the observed increase in the cumulative num-
ber of parenteral feeding days. 
In addition, the administration of predominantly for-
mula feeding was associated with an increased risk of de-
veloping NEC. Both the presence of intact bovine proteins 
leading to intestinal inflammation [24] and the absence of 
human milk with associated protective properties [25] 
contribute to this increased risk. During this study, two 
centers started with supplementation of donor milk in 
cases where the production of the own mother’s milk was 
insufficient. In the current study, we did not differentiate 
between donor milk and the own mother’s milk. However, 
since supplementation with either donor milk or formula 
yielded similar short-term outcomes such as NEC [26], we 
hypothesize that the observed protective effect of the own 
mother’s milk may potentially be higher than observed.
A strength of the current study is the prospective de-
sign with detailed daily data collection at 9 centers allow-
ing us to match each case with 5 controls. By not includ-
ing center of birth in the matching procedure, inter-cen-
ter differences in medical policies (e.g., regarding feeding 
practices or types of antibiotics), potentially causing an 
increased risk of developing NEC, would possibly have 
been identified in the current study. This study also has 
several limitations. Firstly, to allow for adequate compar-
isons in the case-control cohort, control infants were 
matched based on their postnatal age. Consequently, all 
control infants at least survived their matched case and, 
therefore, may not have been an adequate representation 
of the overall population. Secondly, since the follow-up 
period was limited, infants developing NEC after this fol-
low-up period may hypothetically have been allocated to 
the control group. However, information concerning the 
development of NEC was collected for the entire NICU 
admission period. None of the selected controls were 
transferred before the corrected postmenstrual age 
(PMA) of 32 weeks. Since the majority of NEC cases oc-
cur before PMA of 30 weeks, the risk that a control infant 
developed NEC after PMA of 32 weeks and, thus, was in-
correctly allocated to the control group is relatively low 
[14]. Thirdly, the current study is limited by the absence 
of detailed obstetric data, such as prenatal exposure to 
corticosteroids, pre-eclampsia, antenatal Doppler ultra-
sound features, chorioamnionitis, and intrapartum signs 
of infection. However, by including retrospectively col-
lected variables to data which have been collected in a 
prospective manner would potentially result in biased 
outcomes and conclusions. Future studies should focus 
on the collection of both clinical and obstetric data while 
simultaneously performing longitudinal microbiota 
analyses to explore any causality between early adminis-
tered antibiotics and the development of NEC. Further-
more, this study dealt with missing enteral and paren-
teral feeding practice values in approximately 10% of all 
included cases. Since all these cases originated from 2 
centers, these values were not missing randomly and 
could, thus, not be statistically corrected for. Lastly, al-
though the detailed manner of data collection allowed for 
the inclusion of a substantial number of different clinical 
variables, this also resulted in an increased risk of false-
positive discoveries (type I error) due to multiple testing.
Future studies should focus on validating the current 
study results by using an external cohort. Based on these 
findings, a prediction model may be constructed, allow-
ing for the early identification and selection of those 
infants at risk of developing NEC. Subsequently, inter-
ventional studies may be performed to explore causality 
between the development of NEC and the currently iden-
tified clinical variables associated with NEC. 
In conclusion, in this multicenter prospective cohort 
study multiple independent risk factors associated with the 
development of NEC were identified: predominate formu-
la feeding and the cumulative number of parenteral feed-
ing days. This is the first prospective multicenter study de-
scribing that exposure to antibiotics initiated within 24 h 
after birth is associated with a decreased risk of developing 
NEC. This observation seems to underline the increasing 
notion that early intestinal colonization might play a piv-
otal role in the pathogenesis of NEC and opens avenues 
towards the development of microbiota-based preventive 
strategies in order to reduce NEC incidences.
Berkhout et al.Neonatology 2018;114:277–284284
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